Can, M. Et Al. 2013. Accelerated infusion rates of rituximab are well tolerated and safe in rheumatology practice: a single-centre experience. CLINICAL RHEUMATOLOGY , vol.32, no.1 , 87-90.

Can, M., Alibaz-Oner, F., Yilmaz-Oner, S., Atagunduz, P., Inanc, N., & Direskeneli, H., (2013). Accelerated infusion rates of rituximab are well tolerated and safe in rheumatology practice: a single-centre experience. CLINICAL RHEUMATOLOGY , vol.32, no.1, 87-90.

Can, Meryem Et Al. "Accelerated infusion rates of rituximab are well tolerated and safe in rheumatology practice: a single-centre experience," CLINICAL RHEUMATOLOGY , vol.32, no.1, 87-90, 2013

Can, Meryem Et Al. "Accelerated infusion rates of rituximab are well tolerated and safe in rheumatology practice: a single-centre experience." CLINICAL RHEUMATOLOGY , vol.32, no.1, pp.87-90, 2013

Can, M. Et Al. (2013) . "Accelerated infusion rates of rituximab are well tolerated and safe in rheumatology practice: a single-centre experience." CLINICAL RHEUMATOLOGY , vol.32, no.1, pp.87-90.

@article{article, author={Meryem Can Et Al. }, title={Accelerated infusion rates of rituximab are well tolerated and safe in rheumatology practice: a single-centre experience}, journal={CLINICAL RHEUMATOLOGY}, year=2013, pages={87-90} }